BioSpace News Archive

Business

NEUROBO PHARMACEUTICALS APPOINTS HYUNG HEON KIM AS CHIEF EXECUTIVE OFFICER AND PRESIDENT

NeuroBo Pharmaceuticals, Inc. today announced the appointment of current Board member, Hyung Heon (“H.H.”) Kim, as the Company’s Chief Executive Officer and President, effective immediately.

August 14, 2023
·
6 min read
BioMidwest

GE HealthCare Receives FDA Clearance for Portrait Mobile, A First-Of-Its-Kind, Wireless Monitoring Solution Aiding Early Detection of Patient Deterioration

GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Portrait Mobile wireless and wearable monitoring solution.

August 14, 2023
·
6 min read
FDA

U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia

U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY ® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia.

August 14, 2023
·
14 min read
Pharm Country

Koneksa Launches Academic Collaboration Program for Parkinson’s Disease

Koneksa announced the first collaboration in the Koneksa Academic Partnership Program for Parkinson’s Disease to incorporate its Neuroscience Toolkit into research programs.

August 14, 2023
·
3 min read
Business

Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (“Sonnet” or the “Company”), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the three months ended June 30, 2023 and provided a business update.

August 14, 2023
·
10 min read
Business

Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101

Panbela Therapeutics, Inc. today announced an Issue Notification for the European patent 2019213664 titled “METHODS FOR PRODUCING (6S,15S)-3,8,13,18- TETRAAZAICOSANE-6,15-DIOL”.

August 14, 2023
·
8 min read
Business

Jaguar Health Reports Second Quarter 2023 Financial Results

Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) today reported consolidated second-quarter 2023 financial results and provided Company updates.

August 14, 2023
·
13 min read
Biotech Bay

Turn Biotechnologies Cell Reprogramming Treatment Showcased in AAD’s First Session on Regenerative Therapies

The first American Academy of Dermatology educational session to discuss the potential of regenerative medicine in dermatologic treatments featured data from Turn Biotechnologies’ ERA™ technology’s reprogramming of skin cells.

August 14, 2023
·
3 min read
Business

Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th

Biotricity Inc. announced that it will host its First Quarter Fiscal Year 2024 Financial Results and Business Update Call on Tuesday, August 15, 2023.

August 14, 2023
·
4 min read
Drug Development

SFA Therapeutics announces results for SFA-002 from Phase 1b Cohort 1 clinical trial for treatment of mild-to-moderate psoriasis

SFA Therapeutics, a clinical-stage biotech using a first-in-class immuno-modulation technology platform, announced positive results from their SFA-002 Phase 1b cohort 1 clinical trial.

August 14, 2023
·
3 min read